An interventional study of Therapeutic alliance in Suicide, sponsored by University Hospital, Caen. Completed at 1 site in France. Open to participants aged 13 Years to 40 Years. Per ClinicalTrials.gov, last updated 2015-08-14.
Sponsored by University Hospital, Caen · Not applicable, Interventional, and Supportive care
Regardless of age, the quality of hospital care, the confidence that the young can have in the health care team, joining parents are pivotal elements and influence followed. Family support is all the more important as 14% of young people realize a new suicidal act within three months of hospitalization for attempted suicide, and that the essential predictors appear to be the young age and quality of intra-family relationships.
The main objective of this study is to determine, through the construction of an instrument to quantify the therapeutic alliance, defined by the characteristics of the mobilization of the entourage and the mutual commitments in the care of nursing teams and the entourage, the role of early therapeutic alliance with the entourage of suicidal youth 13-40 years, whether primosuicidants or repeat offenders, on short and medium term recurrences and early mortality.
701 studies on the registry are indexed under Suicide; 183 are open to participants now.
This study's enrollment of 292 is above the median of 104 across 560 interventional studies indexed under Suicide.
Browse Suicide studies →University Hospital, Caen is the lead sponsor of 505 studies on the registry; 80 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Other: Therapeutic alliance
characteristics of the mobilization of the entourage evaluated with Family Assessment Device
Time frame: baseline
This study is completed, as verified in Aug 2015. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital, Caen